Troglitazone is an orally active PPARγ agonist, with EC50s of 550 nM and 780 nM for human and murine?PPARγ receptor, respectively. Troglitazone has anticancer activity, prevents and inhibits the development of type 2 diabetes.
Keywords: buy Troglitazone | Troglitazone ic50 | Troglitazone price | Troglitazone cost | Troglitazone solubility dmso | Troglitazone purchase | Troglitazone manufacturer | Troglitazone research buy | Troglitazone order | Troglitazone mouse | Troglitazone chemical structure | Troglitazone mw | Troglitazone molecular weight | Troglitazone datasheet | Troglitazone supplier | Troglitazone in vitro | Troglitazone cell line | Troglitazone concentration | Troglitazone nmr